**Core Concept**
Focal Nodular Hyperplasia (FNH) is a benign hepatic lesion characterized by a nodular architecture and normal liver cell function. Nuclear imaging techniques, particularly those using Technetium-99m labeled hexamethylpropylene amine oxime (HMPAO), can help differentiate FNH from other hepatic lesions due to its unique radiopharmacokinetic properties.

**Why the Correct Answer is Right**
FNH contains normal liver cells, which take up the radiotracer similarly to normal liver tissue. In contrast, other hepatic lesions like Hepatocellular Carcinoma (HCC) and Cholangiocarcinoma often have altered cellular function, leading to reduced or delayed uptake of the radiotracer. Hepatic Adenoma, on the other hand, typically shows increased uptake due to its highly vascular nature. The characteristic "double-donut" sign on nuclear imaging, where the center of the lesion is spared, is highly suggestive of FNH.

**Why Each Wrong Option is Incorrect**
**Option A:** Hepatocellular Carcinoma often shows reduced or delayed uptake of the radiotracer due to its altered cellular function and reduced blood flow.
**Option B:** Hepatic Adenoma typically shows increased uptake of the radiotracer due to its highly vascular nature, making it distinguishable from FNH.
**Option D:** Cholangiocarcinoma can cause biliary obstruction, leading to increased radiotracer uptake in the affected area, but it is not as characteristic as the "double-donut" sign seen in FNH.

**Clinical Pearl / High-Yield Fact**
When using nuclear imaging to diagnose hepatic lesions, it is essential to consider the radiopharmacokinetic properties of the lesion and the characteristics of the radiotracer used. FNH's unique behavior on nuclear imaging makes it an exception, where the "double-donut" sign can be a reliable diagnostic clue.

**✓ Correct Answer: C. Focal Nodular Hyperplasia**